Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
State health officials and visiting physicians clash over hydroxychloroquine policy as ADH presents COVID-19 data
Summary
At a joint Insurance & Commerce committee hearing, Arkansas Department of Health officials reported case counts, contact-tracing capacity and nursing-home impacts while outside physicians urged broader use of hydroxychloroquine; ADH said it does not endorse the drug but physicians retain legal authority to prescribe off-label.
Arkansas Department of Health Secretary Jose R. Romero and State Epidemiologist Dr. Jennifer Dillahaie provided the Insurance & Commerce committee with updated COVID-19 case counts, demographic breakdowns and an overview of the state’s contact-tracing capacity, then faced extended questioning and competing medical testimony over hydroxychloroquine.
Dillahaie told the committee that, through the most recent reporting update, Arkansas recorded about 60,859 cumulative cases with roughly 54,408 recoveries and 784 deaths. She described the demographic distribution of active cases, said nursing-home residents and staff account for a substantial portion of outbreaks in congregate settings and noted maps and reports are updated twice weekly on the ADH website.
On contact tracing, Dillahaie said ADH is working with two contractors — General Dynamics Information Technologies and the Arkansas Foundation…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
